Issued Patents All Time
Showing 1–25 of 63 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12344656 | Genetically engineered T cells having improved persistence in culture | Demetrios Kalaitzidis, Hanspeter Waldner | 2025-07-01 |
| 12304968 | T-cells expressing anti-LIV1 chimeric antigen receptor | Jason Gary Sagert | 2025-05-20 |
| 12227763 | Methods and compositions for treating cancer | Demetrios Kalaitzidis, Mary-Lee Dequeant, Zinkal Samir Padalia | 2025-02-18 |
| 12146157 | Anti-PTK7 immune cell cancer therapy | Jason Gary Sagert | 2024-11-19 |
| 12037616 | Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditions | Yi-Shan Chen, Sandeep Soni, Laura Serwer, John KULMAN | 2024-07-16 |
| 11926676 | Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such | Jason Gary Sagert, Jui Dutta-Simmons | 2024-03-12 |
| 11753466 | Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof | James William West, Jason Gary Sagert, Annie Yang Weaver, Luc Desnoyers, Shweta Singh | 2023-09-12 |
| 11649438 | Methods and compositions for treating cancer | Demetrios Kalaitzidis, Mary-Lee Dequeant, Zinkal Samir Padalia | 2023-05-16 |
| 11622977 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Demetrios Kalaitzidis, Lawrence Klein | 2023-04-11 |
| 11548944 | Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof | Stephen Moore, Margaret Thy Luu Nguyen, Daniel Robert Hostetter, Olga Vasiljeva, Jason Gary Sagert +1 more | 2023-01-10 |
| 11548943 | Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof | Stephen Moore, Margaret Thy Luu Nguyen, Daniel Robert Hostetter, Olga Vasiljeva, Jason Gary Sagert +1 more | 2023-01-10 |
| 11471491 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Demetrios Kalaitzidis, Lawrence Klein | 2022-10-18 |
| 11472875 | Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof | Stephen Moore, Margaret Thy Luu Nguyen, Daniel Robert Hostetter, Olga Vasiljeva, Jason Gary Sagert +1 more | 2022-10-18 |
| 11389481 | Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19 | Mark Benton, Tony Ho, Demetrios Kalaitzidis, Ewelina Morawa | 2022-07-19 |
| 11298378 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Demetrios Kalaitzidis, Lawrence Klein | 2022-04-12 |
| 11267896 | Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof | Jason Gary Sagert, Kimberly Ann Tipton, Shweta Singh, Annie Yang Weaver, Luc Desnoyers | 2022-03-08 |
| 11254912 | Methods and compositions for treating cancer | Demetrios Kalaitzidis, Mary-Lee Dequeant, Zinkal Samir Padalia | 2022-02-22 |
| 11207351 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Demetrios Kalaitzidis, Lawrence Klein | 2021-12-28 |
| 11202802 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Demetrios Kalaitzidis, Lawrence Klein | 2021-12-21 |
| 11191783 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Demetrios Kalaitzidis, Lawrence Klein | 2021-12-07 |
| 11174316 | Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof | James William West, Li Mei, Stephen Moore, Margaret Thy Luu Nguyen, Daniel Robert Hostetter +2 more | 2021-11-16 |
| 11166985 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Demetrios Kalaitzidis, Lawrence Klein | 2021-11-09 |
| 11135247 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Demetrios Kalaitzidis, Lawrence Klein | 2021-10-05 |
| 11071755 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Demetrios Kalaitzidis, Lawrence Klein | 2021-07-27 |
| 11046759 | Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof | Stephen Moore, Margaret Thy Luu Nguyen, Daniel Robert Hostetter, Olga Vasiljeva, Jason Gary Sagert +1 more | 2021-06-29 |